Indivior (NASDAQ:INDV) Issues Quarterly Earnings Results

Indivior (NASDAQ:INDV) posted its earnings results on Thursday. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.26, FiscalAI reports. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. The business had revenue of $356.00 million during the quarter, compared to analyst estimates of $329.35 million.

Indivior Price Performance

Indivior stock traded up $0.48 during trading hours on Thursday, reaching $35.25. The stock had a trading volume of 4,934,641 shares, compared to its average volume of 2,221,596. The company has a market cap of $4.16 billion, a price-to-earnings ratio of 12.63 and a beta of 0.87. Indivior has a 52 week low of $27.68 and a 52 week high of $42.81. The business’s 50 day moving average price is $35.32 and its 200-day moving average price is $35.62.

Indivior Dividend Announcement

The firm also recently disclosed a special dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 30th will be paid a $8.13 dividend.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Barclays lifted their price objective on Indivior from $43.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday. Craig Hallum reiterated a “buy” rating and issued a $53.00 price target on shares of Indivior in a report on Tuesday, August 4th. Zacks Research raised shares of Indivior from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. Finally, Weiss Ratings lowered Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $45.50.

Insider Buying and Selling

In related news, CAO Woodrow D. Anderson bought 1,500 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were purchased at an average cost of $35.69 per share, with a total value of $53,535.00. Following the completion of the acquisition, the chief accounting officer directly owned 27,638 shares in the company, valued at approximately $986,400.22. The trade was a 5.74% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.74% of the stock is currently owned by corporate insiders.

About Indivior

Indivior PLC (NASDAQ:INDV) is a global pharmaceutical company focused on developing and commercializing medicines for substance use disorders and serious mental health conditions. Its portfolio is centered on treatments for opioid use disorder, opioid overdose, and related medical needs.

The company’s principal products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and other formulations; and Opvee, a nalmefene nasal spray intended for the emergency treatment of known or suspected opioid overdose.